E-LIB Suche - Ergebnisse für: ABRAHAM, THEODORE P.

1

Safety and Efficacy of Metabolic Modulation With Ninerafaxs..:

Maron, Martin S. ; Mahmod, Masliza ; Abd Samat, Azlan Helmy...
Journal of the American College of Cardiology. , 2024

Link: https://doi.org/10.1016/..

2

Baseline Characteristics of Patients in SEQUOIA-HCM: A Phas..:

Maron, Martin S. ; Abraham, Theodore P. ; Coats, Caroline J....
Journal of Cardiac Failure. 30 (2024) - p. S3 , 2024

Link: https://doi.org/10.1016/..

3

Mavacamten Treatment for Symptomatic Obstructive Hypertroph..:

Rader, Florian ; Oręziak, Artur ; Choudhury, Lubna...
JACC: Heart Failure. 12 (2024) 1 - p. 164-177 , 2024

Link: https://doi.org/10.1016/..

4

Role of Imaging in the Diagnosis, Evaluation, and Managemen..:

Abraham, Maria Roselle ; Abraham, Theodore P.
The American Journal of Cardiology. 212 (2024) - p. S14-S32 , 2024

Link: https://doi.org/10.1016/..

5

Exercise Capacity in Patients With Obstructive Hypertrophic..:

Coats, Caroline J. ; Maron, Martin S. ; Abraham, Theodore P....
JACC: Heart Failure. 12 (2024) 1 - p. 199-215 , 2024

Link: https://doi.org/10.1016/..

6

Efficacy and Safety of Aficamten in Symptomatic Nonobstruct..:

MASRI, AHMAD ; SHERRID, MARK V. ; ABRAHAM, THEODORE P....
Journal of Cardiac Failure. , 2024

Link: https://doi.org/10.1016/..

7

Geomeric and functional aspects in hypertension and takotsu..:

Yalçin, Fatih ; Çağatay, Boran ; Küçükler, Nagehan.
European Journal of Preventive Cardiology. 30 (2023) 18 - p. 1996-1997 , 2023

Link: https://doi.org/10.1093/..

8

Mavacamten: a first-in-class myosin inhibitor for obstructi..:

Braunwald, Eugene ; Saberi, Sara ; Abraham, Theodore P..
European Heart Journal. 44 (2023) 44 - p. 4622-4633 , 2023

Link: https://doi.org/10.1093/..

9

Efficacy And Safety Of Aficamten In Patients With Symptomat..:

Masri, Ahmad ; Abraham, Theodore P. ; Choudhury, Lubna...
Journal of Cardiac Failure. 29 (2023) 4 - p. 554 , 2023

Link: https://doi.org/10.1016/..

10

A call to consider an aortic stenosis screening program:

Bae, Ju Young ; Fallahi, Arzhang ; Miller, Wayne...
Trends in Cardiovascular Medicine. , 2023

Link: https://doi.org/10.1016/..

11

Patient-Level Artificial Intelligence–Enhanced Electrocardi..:

Siontis, Konstantinos C. ; Abreau, Sean ; Attia, Zachi I....
JACC: Advances. 2 (2023) 8 - p. 100582 , 2023

Link: https://doi.org/10.1016/..

12

Systolic blood pressure ≤110 mm Hg is associated with sever..:

Lu, Dai-Yin ; Yalcin, Hulya ; Yalcin, Fatih...
Heart Rhythm O2. 4 (2023) 9 - p. 538-548 , 2023

Link: https://doi.org/10.1016/..

13

Prevalence and prognostic implications of hypertensive resp..:

Lu, Dai-Yin ; Ventoulis, Ioannis ; Liu, Hongyun...
International Journal of Cardiology Cardiovascular Risk and Prevention. 16 (2023) - p. 200166 , 2023

Link: https://doi.org/10.1016/..

14

Energetics of Cardiac Blood Flow in Hypertrophic Cardiomyop..:

Baenen, Owen ; Carreño-Martínez, Angie Carolina ; Abraham, Theodore P..
Journal of Cardiovascular Development and Disease. 10 (2023) 10 - p. 411 , 2023

Link: https://doi.org/10.3390/..

15

Aficamten for Drug-Refractory Severe Obstructive Hypertroph..:

OWENS, ANJALI T. ; MASRI, AHMAD ; ABRAHAM, THEODORE P....
Journal of Cardiac Failure. 29 (2023) 11 - p. 1576-1582 , 2023

Link: https://doi.org/10.1016/..